474 related articles for article (PubMed ID: 14692706)
1. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
Vrecer M; Turk S; Drinovec J; Mrhar A
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
Thavendiranathan P; Bagai A; Brookhart MA; Choudhry NK
Arch Intern Med; 2006 Nov; 166(21):2307-13. PubMed ID: 17130382
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.
Hebert PR; Gaziano JM; Chan KS; Hennekens CH
JAMA; 1997 Jul 23-30; 278(4):313-21. PubMed ID: 9228438
[TBL] [Abstract][Full Text] [Related]
5. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
LaRosa JC; He J; Vupputuri S
JAMA; 1999 Dec 22-29; 282(24):2340-6. PubMed ID: 10612322
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients.
O'Regan C; Wu P; Arora P; Perri D; Mills EJ
Am J Med; 2008 Jan; 121(1):24-33. PubMed ID: 18187070
[TBL] [Abstract][Full Text] [Related]
7. Statins for the primary prevention of cardiovascular disease.
Taylor F; Ward K; Moore TH; Burke M; Davey Smith G; Casas JP; Ebrahim S
Cochrane Database Syst Rev; 2011 Jan; (1):CD004816. PubMed ID: 21249663
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Baigent C; Keech A; Kearney PM; Blackwell L; Buck G; Pollicino C; Kirby A; Sourjina T; Peto R; Collins R; Simes R;
Lancet; 2005 Oct; 366(9493):1267-78. PubMed ID: 16214597
[TBL] [Abstract][Full Text] [Related]
9. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
; Mihaylova B; Emberson J; Blackwell L; Keech A; Simes J; Barnes EH; Voysey M; Gray A; Collins R; Baigent C
Lancet; 2012 Aug; 380(9841):581-90. PubMed ID: 22607822
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in statin treatment trials: a meta-analysis.
Ross SD; Allen IE; Connelly JE; Korenblat BM; Smith ME; Bishop D; Luo D
Arch Intern Med; 1999 Aug 9-23; 159(15):1793-802. PubMed ID: 10448784
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.
Cheung BM; Lauder IJ; Lau CP; Kumana CR
Br J Clin Pharmacol; 2004 May; 57(5):640-51. PubMed ID: 15089818
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
; Baigent C; Blackwell L; Emberson J; Holland LE; Reith C; Bhala N; Peto R; Barnes EH; Keech A; Simes J; Collins R
Lancet; 2010 Nov; 376(9753):1670-81. PubMed ID: 21067804
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
; Fulcher J; O'Connell R; Voysey M; Emberson J; Blackwell L; Mihaylova B; Simes J; Collins R; Kirby A; Colhoun H; Braunwald E; La Rosa J; Pedersen TR; Tonkin A; Davis B; Sleight P; Franzosi MG; Baigent C; Keech A
Lancet; 2015 Apr; 385(9976):1397-405. PubMed ID: 25579834
[TBL] [Abstract][Full Text] [Related]
14. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials.
Bucher HC; Griffith LE; Guyatt GH
Ann Intern Med; 1998 Jan; 128(2):89-95. PubMed ID: 9441587
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of statin therapy in adults with coronary heart disease.
Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A
Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352
[TBL] [Abstract][Full Text] [Related]
16. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.
Cholesterol Treatment Trialists' Collaboration
Lancet; 2019 Feb; 393(10170):407-415. PubMed ID: 30712900
[TBL] [Abstract][Full Text] [Related]
18. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.
Afilalo J; Duque G; Steele R; Jukema JW; de Craen AJ; Eisenberg MJ
J Am Coll Cardiol; 2008 Jan; 51(1):37-45. PubMed ID: 18174034
[TBL] [Abstract][Full Text] [Related]
19. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
20. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
Preiss D; Campbell RT; Murray HM; Ford I; Packard CJ; Sattar N; Rahimi K; Colhoun HM; Waters DD; LaRosa JC; Amarenco P; Pedersen TR; Tikkanen MJ; Koren MJ; Poulter NR; Sever PS; Ridker PM; MacFadyen JG; Solomon SD; Davis BR; Simpson LM; Nakamura H; Mizuno K; Marfisi RM; Marchioli R; Tognoni G; Athyros VG; Ray KK; Gotto AM; Clearfield MB; Downs JR; McMurray JJ
Eur Heart J; 2015 Jun; 36(24):1536-46. PubMed ID: 25802390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
